CAM
ENZY

ClariVest Asset Management’s Enzymotec Ltd ENZY Stock Holding History

ClariVest Asset Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,735
Closed -$90K – 777
2016
Q2 		$90K Hold
10,735
– – ﹤0.01% 533
2016
Q1 		$97K Hold
10,735
– – ﹤0.01% 514
2015
Q4 		$105K Buy
+10,735
New +$102K ﹤0.01% 506

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

ClariVest Asset Management's ENZY Position: Q3 2016 in Review

ClariVest Asset Management sold out of Enzymotec Ltd (ENZY) in Q3 2016, closing a stake of 10,735 shares — an estimated $90K sold.

ClariVest Asset Management first reported a position in ENZY in Q4 2015 and held it in 3 quarters. The position peaked at $105K in Q4 2015. 34 funds tracked by Wall St. Rank hold ENZY as of Q3 2016.

  • ClariVest Asset Management reported no remaining Enzymotec Ltd position as of Q3 2016 after selling out during the quarter.
  • ClariVest Asset Management sold 10,735 Enzymotec Ltd shares in Q3 2016, an estimated $90K.
  • ClariVest Asset Management first reported a position in Enzymotec Ltd in Q4 2015 and held it in 3 quarters.
  • ClariVest Asset Management's Enzymotec Ltd position peaked at $105K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q3 2016.

Based on ClariVest Asset Management's 13F filing for Q3 2016, filed 7 Nov 2016.